Global
EN
Uteroton Forte
Propranolol, oxytocin
Where to buy
Propranolol, oxytocin

Uteroton Forte

to the catalogue

Unique combination of propranolol and oxytocin which provides prevention and treatment of obstetric and gynecological diseases in cows after a single administration in complex therapy

  • Provides optimal duration of action due to the synergistic effect
  • Effective for the prevention of diseases in the postpartum period
  • Convenience of a single injection
Composition
Pharmacological properties
Indications
Dosage and method of administration
Restrictions
1 ml Uteroton Forte
propranolol 50 mg
oxytocin 30 IU
Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Pharmacological properties
Uteroton Forte belongs to the group of non-selective beta-blockers in combinations.

Propranolol has a blocking effect on the beta-adrenergic receptors of the myometrium, which contributes to the activity of endogenous oxytocin, resulting in increased contractions of the smooth muscles of the uterus and mammary gland. It is a catecholamine antagonist and has a pronounced anti-stress effect.

Oxytocin is a synthetic polypeptide analog of the hormone of the posterior pituitary gland. It has a stimulating effect on the smooth muscles of the uterus, especially at the end of pregnancy, as well as during labor by increasing the permeability of cell membranes to calcium ions and increasing its intracellular concentration. Under the influence of oxytocin, the resting potential of the membrane decreases and its excitability increases. It causes contractions, increases the contractility of the uterus.
Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Indications

Uteroton Forte is used in cows:

  • to stimulate labor in case of atony, hypotension of the uterus
  • to prevent afterbirth retention and uterine subinvolution
  • to treat postpartum endometritis in cows as part of complex therapy

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Dosage and method of administration

Specie

Indication

Method of administration

Dosage

Treatment course

Cattle


Stimulatation of labor (in case of atony, hypotension of the uterus)

Intramuscularly 

1-3 ml/animal on the day of delivery

Once

Separation of the afterbirth

Prevention of postpartum complications

After retention of the afterbirth

3 ml/animal

Treatment of uterine subinvolution

5 ml/animal

Treatment of postpartum endometritis

7-10 ml/animal

For preventive purposes, the drug is administered to animals once every 2-3 weeks, for therapeutic purposes – once every 7-10 days. In pregnant sows, the drug is administered 3-4 weeks before farrowing, in dry cows –1-1.5 months before calving. When administered orally, the drug is given to animals in a mixture with feed for three weeks. At the same time, it is necessary to balance the diets of protein, calcium, phosphorus, magnesium and trace elements.

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.
Restrictions

Contraindications and special instructions:

Do not use during pregnancy and in case of abnormal fetal position, as well as in case of individual hypersensitivity.

Simultaneous use of the drug with adrenomimetics, non-depolarizing muscle relaxants, sedatives and hypnotics is not recommended due to the possible increased depressive effect on the central nervous system, and iodine-containing drugs administered intravenously and intramuscularly due to an increased risk of anaphylactic reactions.

Withdrawal period:
meat: 0 days
milk: 0 days

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.

Similar products